Clinical Trial

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
Protocol Amendment History 23 amendments
This ClinicalTrials.gov record has been amended 23 times since 2024-08-12; most recent amendment 2026-07-02.
Trial Details
NCT Number NCT06553625
Lead Sponsor Boston Scientific Corporation
Conditions Parkinson Disease, Dystonia, Essential Tremor, Movement Disorders
Enrollment 200 participants
Start Date 2024-01-29
Primary Completion 2035-12 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-04